Oui, le tabagisme peut augmenter la production d'acide et affaiblir le sphincter œsophagien.
TabagismeAcidité gastriqueSphincter œsophagien
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Ésoméprazole : Questions médicales les plus fréquentes",
"headline": "Ésoméprazole : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Ésoméprazole : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-19",
"dateModified": "2026-03-11",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Ésoméprazole"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Oméprazole",
"url": "https://questionsmedicales.fr/mesh/D009853",
"about": {
"@type": "MedicalCondition",
"name": "Oméprazole",
"code": {
"@type": "MedicalCode",
"code": "D009853",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.103.034.500"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Ésoméprazole",
"alternateName": "Esomeprazole",
"code": {
"@type": "MedicalCode",
"code": "D064098",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "In-Jin Jang",
"url": "https://questionsmedicales.fr/author/In-Jin%20Jang",
"affiliation": {
"@type": "Organization",
"name": "Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea."
}
},
{
"@type": "Person",
"name": "SeungHwan Lee",
"url": "https://questionsmedicales.fr/author/SeungHwan%20Lee",
"affiliation": {
"@type": "Organization",
"name": "Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea. Electronic address: leejh413@snu.ac.kr."
}
},
{
"@type": "Person",
"name": "Yohannes T Ghebre",
"url": "https://questionsmedicales.fr/author/Yohannes%20T%20Ghebre",
"affiliation": {
"@type": "Organization",
"name": "Department of Radiation Oncology, Baylor College of Medicine, Houston, Texas 77030, USA."
}
},
{
"@type": "Person",
"name": "Sung Hee Hong",
"url": "https://questionsmedicales.fr/author/Sung%20Hee%20Hong",
"affiliation": {
"@type": "Organization",
"name": "Hanmi Pharmaceutical Co., Ltd., Seoul, Republic of Korea; Department of Pharmaceutical Medicine and Regulatory Science, Yonsei University, Incheon, Republic of Korea."
}
},
{
"@type": "Person",
"name": "Min Wang",
"url": "https://questionsmedicales.fr/author/Min%20Wang",
"affiliation": {
"@type": "Organization",
"name": "Department of Radiation Oncology, Baylor College of Medicine, Houston, Texas 77030, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Patient Preparation with Esomeprazole Is Comparable to Ranitidine in Meckel Diverticulum Scintigraphy.",
"datePublished": "2023-06-14",
"url": "https://questionsmedicales.fr/article/37316300",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2967/jnmt.123.265558"
}
},
{
"@type": "ScholarlyArticle",
"name": "Structural characterization of the optical isomers esomeprazole and omeprazole using the JADER and FAERS databases.",
"datePublished": "2023-07-22",
"url": "https://questionsmedicales.fr/article/37482254",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.taap.2023.116632"
}
},
{
"@type": "ScholarlyArticle",
"name": "Comparative Efficacy of Tegoprazan vs Esomeprazole/Sodium Bicarbonate for the Treatment of Helicobacter pylori Infection.",
"datePublished": "2023-11-01",
"url": "https://questionsmedicales.fr/article/37561041",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.14309/ctg.0000000000000632"
}
},
{
"@type": "ScholarlyArticle",
"name": "Pharmacokinetics, Bioequivalence, and Safety of Esomeprazole Magnesium Enteric-Coated Capsules in Healthy Chinese Subjects.",
"datePublished": "2023-06-17",
"url": "https://questionsmedicales.fr/article/37329259",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/cpdd.1273"
}
},
{
"@type": "ScholarlyArticle",
"name": "CYP2C19 loss-of-function alleles and use of omeprazole or esomeprazole increase the risk of cardiovascular outcomes in patients using clopidogrel.",
"datePublished": "2023-08-16",
"url": "https://questionsmedicales.fr/article/37551775",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/cts.13608"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés hétérocycliques",
"item": "https://questionsmedicales.fr/mesh/D006571"
},
{
"@type": "ListItem",
"position": 3,
"name": "Composés hétérocycliques à cycles fusionnés",
"item": "https://questionsmedicales.fr/mesh/D000072471"
},
{
"@type": "ListItem",
"position": 4,
"name": "Composés hétérobicycliques",
"item": "https://questionsmedicales.fr/mesh/D006574"
},
{
"@type": "ListItem",
"position": 5,
"name": "Benzimidazoles",
"item": "https://questionsmedicales.fr/mesh/D001562"
},
{
"@type": "ListItem",
"position": 6,
"name": "(Pyridin-2-ylméthyl)sulfinyl-1H-benzimidazoles",
"item": "https://questionsmedicales.fr/mesh/D053799"
},
{
"@type": "ListItem",
"position": 7,
"name": "Oméprazole",
"item": "https://questionsmedicales.fr/mesh/D009853"
},
{
"@type": "ListItem",
"position": 8,
"name": "Ésoméprazole",
"item": "https://questionsmedicales.fr/mesh/D064098"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Ésoméprazole - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Ésoméprazole",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-05-14",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Ésoméprazole",
"description": "Comment diagnostiquer un reflux gastro-œsophagien ?\nQuels tests pour évaluer l'efficacité de l'esoméprazole ?\nQuels symptômes indiquent un besoin d'esoméprazole ?\nQuand consulter un médecin pour des douleurs gastriques ?\nQuels signes nécessitent une endoscopie ?",
"url": "https://questionsmedicales.fr/mesh/D064098#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Ésoméprazole",
"description": "Quels sont les effets secondaires de l'esoméprazole ?\nL'esoméprazole cause-t-il des douleurs abdominales ?\nQuels symptômes indiquent une surdose d'esoméprazole ?\nComment reconnaître une réaction allergique à l'esoméprazole ?\nL'esoméprazole peut-il provoquer des maux de tête ?",
"url": "https://questionsmedicales.fr/mesh/D064098#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Ésoméprazole",
"description": "Comment prévenir les brûlures d'estomac ?\nL'esoméprazole peut-il être utilisé en prévention ?\nQuelles habitudes de vie aident à prévenir le reflux ?\nQuels aliments éviter pour prévenir l'acidité ?\nComment le stress influence-t-il l'acidité gastrique ?",
"url": "https://questionsmedicales.fr/mesh/D064098#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Ésoméprazole",
"description": "Comment l'esoméprazole agit-il sur l'acidité ?\nQuelle est la posologie standard de l'esoméprazole ?\nPeut-on prendre l'esoméprazole avec d'autres médicaments ?\nCombien de temps faut-il pour que l'esoméprazole agisse ?\nL'esoméprazole est-il efficace contre les ulcères ?",
"url": "https://questionsmedicales.fr/mesh/D064098#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Ésoméprazole",
"description": "Quelles complications peuvent survenir avec l'esoméprazole ?\nL'esoméprazole peut-il causer des problèmes rénaux ?\nQuels risques à long terme de l'esoméprazole ?\nComment l'esoméprazole affecte-t-il l'absorption des nutriments ?\nQuelles sont les complications du reflux non traité ?",
"url": "https://questionsmedicales.fr/mesh/D064098#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Ésoméprazole",
"description": "Quels sont les facteurs de risque du reflux ?\nL'âge influence-t-il le risque de reflux ?\nLe stress est-il un facteur de risque pour l'acidité ?\nLes médicaments peuvent-ils augmenter le risque de reflux ?\nLe tabagisme influence-t-il l'acidité gastrique ?",
"url": "https://questionsmedicales.fr/mesh/D064098#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer un reflux gastro-œsophagien ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par endoscopie, pH-métrie et évaluation des symptômes."
}
},
{
"@type": "Question",
"name": "Quels tests pour évaluer l'efficacité de l'esoméprazole ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "On utilise des tests de pH, des endoscopies et l'évaluation des symptômes cliniques."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un besoin d'esoméprazole ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des brûlures d'estomac, des régurgitations acides et des douleurs thoraciques."
}
},
{
"@type": "Question",
"name": "Quand consulter un médecin pour des douleurs gastriques ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Consultez si les douleurs persistent malgré les antiacides ou s'aggravent."
}
},
{
"@type": "Question",
"name": "Quels signes nécessitent une endoscopie ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des saignements, des difficultés à avaler ou une perte de poids inexpliquée justifient une endoscopie."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires de l'esoméprazole ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires peuvent inclure des maux de tête, des nausées et des diarrhées."
}
},
{
"@type": "Question",
"name": "L'esoméprazole cause-t-il des douleurs abdominales ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des douleurs abdominales peuvent survenir, mais elles sont généralement légères."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une surdose d'esoméprazole ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme des vertiges, des palpitations et des éruptions cutanées peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une réaction allergique à l'esoméprazole ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des éruptions cutanées, des démangeaisons ou un gonflement du visage peuvent indiquer une allergie."
}
},
{
"@type": "Question",
"name": "L'esoméprazole peut-il provoquer des maux de tête ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les maux de tête sont un effet secondaire courant de l'esoméprazole."
}
},
{
"@type": "Question",
"name": "Comment prévenir les brûlures d'estomac ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Évitez les aliments gras, le tabac et mangez de petites portions pour prévenir les brûlures."
}
},
{
"@type": "Question",
"name": "L'esoméprazole peut-il être utilisé en prévention ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut être prescrit pour prévenir les ulcères chez les patients à risque."
}
},
{
"@type": "Question",
"name": "Quelles habitudes de vie aident à prévenir le reflux ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir un poids santé, éviter de s'allonger après les repas et réduire le stress aide."
}
},
{
"@type": "Question",
"name": "Quels aliments éviter pour prévenir l'acidité ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Évitez les agrumes, le chocolat, les boissons gazeuses et les aliments épicés."
}
},
{
"@type": "Question",
"name": "Comment le stress influence-t-il l'acidité gastrique ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress peut augmenter la production d'acide, aggravant les symptômes de reflux."
}
},
{
"@type": "Question",
"name": "Comment l'esoméprazole agit-il sur l'acidité ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il inhibe la pompe à protons, réduisant ainsi la production d'acide gastrique."
}
},
{
"@type": "Question",
"name": "Quelle est la posologie standard de l'esoméprazole ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La posologie standard est généralement de 20 à 40 mg par jour, selon l'indication."
}
},
{
"@type": "Question",
"name": "Peut-on prendre l'esoméprazole avec d'autres médicaments ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, mais il est important de consulter un médecin pour éviter les interactions."
}
},
{
"@type": "Question",
"name": "Combien de temps faut-il pour que l'esoméprazole agisse ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'effet peut être ressenti en 1 à 2 jours, mais un traitement complet est souvent nécessaire."
}
},
{
"@type": "Question",
"name": "L'esoméprazole est-il efficace contre les ulcères ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il est utilisé pour traiter les ulcères gastriques et duodénaux en réduisant l'acidité."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec l'esoméprazole ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications rares incluent des infections gastro-intestinales et des carences en nutriments."
}
},
{
"@type": "Question",
"name": "L'esoméprazole peut-il causer des problèmes rénaux ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études suggèrent un lien entre l'utilisation prolongée et des problèmes rénaux."
}
},
{
"@type": "Question",
"name": "Quels risques à long terme de l'esoméprazole ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'utilisation prolongée peut augmenter le risque de fractures et d'infections intestinales."
}
},
{
"@type": "Question",
"name": "Comment l'esoméprazole affecte-t-il l'absorption des nutriments ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il peut réduire l'absorption de certains nutriments comme le calcium et la vitamine B12."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications du reflux non traité ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le reflux non traité peut entraîner des œsophagites, des ulcères et des complications respiratoires."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque du reflux ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'obésité, le tabagisme, une alimentation riche en graisses et le stress."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque de reflux ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque de reflux augmente avec l'âge en raison de la diminution de la motilité œsophagienne."
}
},
{
"@type": "Question",
"name": "Le stress est-il un facteur de risque pour l'acidité ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut exacerber les symptômes d'acidité et de reflux."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils augmenter le risque de reflux ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains médicaments, comme les anti-inflammatoires, peuvent aggraver le reflux."
}
},
{
"@type": "Question",
"name": "Le tabagisme influence-t-il l'acidité gastrique ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme peut augmenter la production d'acide et affaiblir le sphincter œsophagien."
}
}
]
}
]
}
Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea. Electronic address: leejh413@snu.ac.kr.
Hanmi Pharmaceutical Co., Ltd., Seoul, Republic of Korea; Department of Pharmaceutical Medicine and Regulatory Science, Yonsei University, Incheon, Republic of Korea.
It is unclear whether the s (-) form of esomeprazole (EPZ) has an improved safety profile when compared with its racemic form omeprazole (OPZ). We assessed the potential complications of these optical...
Using two adverse event spontaneous reporting databases, Japanese Adverse Drug Event Report (JADER) and FDA Adverse Event Reporting System (FAERS), adverse event names for hemorrhage, venous/arterial ...
In combination with cilostazol, a hemorrhagic signal for OPZ in JADER and arterial emboli and thrombus signals for EPZ were detected in both databases. In combination with clopidogrel, OPZ showed arte...
This study has confirmed using big data, that EPZ, the optical isomer and racemic form of omeprazole, has the beneficial characteristics of being less sensitive to CYP, as was intended by its design....
Potassium-competitive acid blockers and proton pump inhibitors/sodium bicarbonate can rapidly increase intragastric pH. In this study, we aimed to compare the clinical outcomes of tegoprazan-based and...
We retrospectively reviewed the data of patients with H. pylori infection treated with a 14-day tegoprazan-based triple therapy or 14-day esomeprazole/sodium bicarbonate-based triple therapy. The prim...
Of the 854 included patients, 435 were treated with tegoprazan-based therapy, and 419 received esomeprazole/sodium bicarbonate-based therapy. In the intention-to-treat population, no significant diffe...
The efficacy of the esomeprazole/sodium bicarbonate-based triple therapy for H. pylori eradication was comparable with that of the tegoprazan-based triple therapy. However, esomeprazole/sodium bicarbo...
This bioequivalence study is critically important for drug production. Recently, a local pharmaceutical company produced esomeprazole magnesium enteric-coated capsules, a major drug to help to eradica...
Our aim was to investigate in a real-life prospective patient cohort how CYP2C19 loss-of-function (LOF) variants and CYP2C19 inhibitor omeprazole or esomeprazole influence the incidence of cardiovascu...
Solid dispersion (SD) technology is one of the most widely preferred solubility enhancement methods, especially for Biopharmaceutics classification system class II and IV drugs. Since the last decade,...
According to the Maastricht VI/Florence consensus report, potassium-competitive acid blockers (P-CAB) may improve Helicobacter pylori eradication treatment....
A total of 213 H. pylori treatment-naive patients aged between 18 and 70 years were treated with two regimens. The two regimens are VDT: 20 mg vonoprazan twice a day and 1 g amoxicillin three times da...
On intention-to-treat (ITT) analysis, the eradication rate in VDT group (89.0%; 95% CI 81.7-96.3) was non-inferior to that in EDT group (87.7%; 95% CI 80.1-95.3; p = 0.796). The corresponding per-prot...
The efficacy and safety of 14-day VDT and EDT were comparable. Therefore, 14-day VDT or EDT may be recommended for the first-line treatment of H. pylori infection....
Quadruple therapy comprising 2 antibiotics, a proton pump inhibitor, and bismuth, is recommended for Helicobacter pylori eradication in China. This Phase 1, double-blind, parallel-group study aimed to...
A fixed-dose combination (FDC) of proton pump inhibitors (PPIs) and antacid salts enables rapid acid suppression through the neutralizing effect of the antacid salt and the rapid absorption of PPIs. T...
A randomized, open-label, multiple-dose, two-treatment, two-way crossover design was conducted in healthy subjects. Forty-nine subjects were randomized to one of the two treatment sequences and receiv...
After multiple administrations, the median value of time to reach maximum concentration was faster in the test drug than in the reference drug, with a difference of 1.68 hours. The overall systemic ex...
The fixed-dose combination of esomeprazole and magnesium hydroxide showed rapid absorption and quicker gastric acid suppression than enteric-coated esomeprazole with comparable PK and PD properties....
gov identifier: NCT04324905 (https://classic....
gov/ct2/show/NCT04324905)....
A man in his 60s presented with a widespread erythematous rash and associated chills, paraesthesia and haematuria. He had recently commenced naproxen/esomeprazole. Blood tests showed hypereosinophilia...